文献速递肾小球疾病

因子H相关蛋白1驱动C3肾小球病的疾病易感性与预后

Factor H-Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 Glomerulopathy.
PubMed 文献 · J Am Soc Nephrol · 2022-05-11

该研究通过体外和体内实验鉴定出具有二聚化结构域重复的FHR-1突变体,并在两个西班牙C3G队列和对照人群中分析CFHR1拷贝数变异和血浆FHR-1水平。发现该突变体增强与C3调理表面的结合并过度激活替代途径;FHR-1遗传缺陷或血浆FHR-1降低与C3G发生风险降低及更好的肾脏预后相关。

要点

  • FHR-1二聚化结构域重复突变体增强与C3调理表面结合,过度激活替代途径。
  • FHR-1遗传缺陷或血浆FHR-1降低与C3G发生风险降低及更好肾脏预后相关。
  • FHR-1可能是C3G的潜在新型治疗靶点。

核心结论

  • FHR-1二聚化结构域重复突变体导致C3G易感性,其机制为结合C3活化片段并招募天然C3和C3b,形成替代途径C3转化酶,增加C3b沉积并克服FH调控。
  • FHR-1遗传缺陷或血浆FHR-1降低与C3G发生风险降低及更好肾脏预后相关。
  • FHR-1被确定为C3G的潜在新型治疗靶点。

研究设计与样本

  • 研究采用体外和体内实验对具有二聚化结构域重复的FHR-1突变体进行广泛表征。
  • 在两个西班牙C3G队列和对照人群中分析CFHR1拷贝数变异和血浆FHR-1水平。

主要发现

  • 二聚化结构域重复赋予FHR-1增强与C3调理表面相互作用的能力,导致替代途径过度激活。
  • 该激活不涉及与因子H竞争结合C3b。
  • FHR-1遗传缺陷或血浆FHR-1降低与C3G发生风险降低及更好肾脏预后相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: C3 glomerulopathy (C3G) is a heterogeneous group of chronic renal diseases characterized predominantly by glomerular C3 deposition and complement dysregulation. Mutations in factor H-related (FHR) proteins resulting in duplicated dimerization domains are prototypical of C3G, although the underlying pathogenic mechanism is unclear. METHODS: Using in vitro and in vivo assays, we performed extensive characterization of an FHR-1 mutant with a duplicated dimerization domain. To assess the FHR-1 mutant's association with disease susceptibility and renal prognosis, we also analyzed CFHR1 copy number variations and FHR-1 plasma levels in two Spanish C3G cohorts and in a control population. RESULTS: Duplication of the dimerization domain conferred FHR-1 with an increased capacity to interact with C3-opsonized surfaces, which resulted in an excessive activation of the alternative pathway. This activation does not involve C3b binding competition with factor H. These findings support a scenario in which mutant FHR-1 binds to C3-activated fragments and recruits native C3 and C3b; this leads to formation of alternative pathway C3 convertases, which increases deposition of C3b molecules, overcoming FH regulation. This suggests that a balanced FHR-1/FH ratio is crucial to control complement amplification on opsonized surfaces. Consistent with this conceptual framework, we show that the genetic deficiency of FHR-1 or decreased FHR-1 in plasma confers protection against developing C3G and associates with better renal outcome. CONCLUSIONS: Our findings explain how FHR-1 mutants with duplicated dimerization domains result in predisposition to C3G. They also provide a pathogenic mechanism that may be shared by other diseases, such as IgA nephropathy or age-related macular degeneration, and identify FHR-1 as a potential novel therapeutic target in C3G.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Márquez-Tirado B, Gutiérrez-Tenorio J, Tortajada A, et al. Factor H-Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 Glomerulopathy. J Am Soc Nephrol. 2022. PMID: 35545301. doi:10.1681/ASN.2021101318

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。